why am i not losing weight on compound tirzepatide TrimRX | Why Am I

In the Phase 2 trial, most of the weight loss occurred after participants reached the 8mg or 12mg target dose

Protein intake should be individualized based on health status, with guidance from a registered dietitian, particularly for those with kidney disease

dosing errors from patients self-administering incorrect amounts from multidose vials a risk inherent to the compounded product format rather than the active ingredient itself

PMC 1462135

Many people begin noticing appetite suppression during this phase

Smoking is most prevalent in adults aged 2544 years, and the uptake of newer products such as e-cigarettes continues to rise in this demographic 4